Showing 11-20 of 23 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes | Regents of the University of Colorado | Xiaofan Jia | Cures | 01-September-2023 to 28-February-2026 | $499.998,96 |
| Defining human T cell-myeloid cell interactions in the islets | Regents of the University of Colorado | Rachel Friedman | Cures | 01-March-2023 to 28-February-2026 | $110.000,00 |
| IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY | Regents of the University of Colorado | Mayumi Fujita | Cures | 01-March-2023 to 28-February-2026 | $750.000,00 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-March-2026 | $900.000,00 |
| Antigenic Targets of CD4 T cells across the stages of type 1 diabetes | Regents of the University of Colorado | Maki Nakayama | Cures | 01-August-2022 to 31-July-2026 | $750.000,00 |
| Expanding Technology Success into Novel Populations: Safety and Feasibility Testing of a Fully Closed Loop System in Adolescents and Young Adults with High Baseline HbA1c Values | Regents of the University of Colorado | Gregory Forlenza | Improving Lives | 01-November-2022 to 30-June-2025 | $999.996,26 |
| Clinical and Economic Optimization Platform for Type 1 Diabetes Screening | Regents of the University of Colorado | R. Brett McQueen | Cures | 01-September-2022 to 31-August-2024 | $483.523,62 |
| Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) | Regents of the University of Colorado | Kristen Nadeau | Improving Lives | 01-December-2021 to 30-November-2025 | $445.816,29 |
| EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM | Regents of the University of Colorado | Janet Snell-Bergeon | Improving Lives | 01-November-2022 to 31-October-2025 | $2.282.771,83 |
| Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | Regents of the University of Colorado | Jessica Kendrick | Improving Lives | 01-October-2022 to 30-September-2025 | $899.235,00 |